Gastroenterologia y hepatologia最新文献_第8页

CARACTERIZACIÓN DE LAS SUBPOBLACIONES DE LINFOCITOS DE LA MUCOSA DUODENAL EN CELIAQUÍA MARSH 1 SERONEGATIVA

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-11-01 DOI: 10.1016/S0210-5705(24)00380-7

A. Martín-Cardona, A. Carrasco, C. Ferrer, B. Arau, M. Ibarra, M. Pujals, Y. Zabana, M. Esteve

引用次数: 0

ELEVACIÓN DE PROTEÍNAS SÉRICAS TRAS LA INGESTA DE GLUTEN

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-11-01 DOI: 10.1016/S0210-5705(24)00382-0

S. Gómez-Aguililla, C. Senosiain, S. Farrais, N. López-Palacios, B. Arau, Á. Ruiz-Carnicer, J. Infante-Menéndez, R. Barderas, A. Montero-Calle, C. Sousa, C. Núñez

引用次数: 0

SITUACIÓN DE LAS PERSONAS CELÍACAS FRENTE AL CONSUMO DE CERVEZAS

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-11-01 DOI: 10.1016/S0210-5705(24)00355-8

M. van der Hofstadt-Rovira

引用次数: 0

EVALUACIÓN DEL RIESGO EN LA ELABORACIÓN DE CERVEZAS SIN GLUTEN

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-11-01 DOI: 10.1016/S0210-5705(24)00353-4

M.P. Fernández-Gil, S. Matías-Ibáñez, L. Cantero-Ruiz de Eguino, J. Esparta, O. Martínez, J. Miranda, E. Simón, M.Á. Bustamante

引用次数: 0

P13. EFECTO DE LA DIETA SIN GLUTEN SOBRE LA MICROBIOTA INTESTINAL DE MUJERES CON ENFERMEDAD CELÍACA

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-11-01 DOI: 10.1016/S0210-5705(24)00395-9

M.M. Morcillo Serrano, R. de la Iglesia González, P.A. Jiménez Gómez, J. Arranz Herrero, D. González Reguero, M.P. Reche Sainz, N. Úbeda, E. Alonso-Aperte

引用次数: 0

P5. HÁBITOS DE CONSUMO DE PAN SIN GLUTEN Y CALIDAD NUTRICIONAL DE PRODUCTOS ALTERNATIVOS A BASE DE BAGAZO DE MANZANA

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-11-01 DOI: 10.1016/S0210-5705(24)00387-X

L. Cantero-Ruiz de Eguino, J. Salmerón, J. Miranda, M.P. Fernández-Gil, E. Simón, S. Matías-Ibáñez, M. Vázquez-Polo, O. Martínez

引用次数: 0

Uso de herramientas digitales en salud en enfermedad inflamatoria intestinal 在炎症性肠病中使用数字健康工具。

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-11-01 DOI: 10.1016/j.gastrohep.2024.502200

{"title":"Uso de herramientas digitales en salud en enfermedad inflamatoria intestinal","authors":"","doi":"10.1016/j.gastrohep.2024.502200","DOIUrl":"10.1016/j.gastrohep.2024.502200","url":null,"abstract":"<div><h3>Objective</h3><div>To analyse the characteristics and use of digital health tools (DHT) in inflammatory bowel disease (IBD).</div></div><div><h3>Methods</h3><div>We performed a qualitative study based on a narrative literature review, a questionnaire and on the opinion of 3 expert gastroenterologists. Several searches were carried out until September 2022 through Medline to identify articles on the use of DHT in IBD by healthcare professionals. A structured questionnaire was designed to be answered by health professionals involved in the care of patients with IBD. The experts generated a set of recommendations.</div></div><div><h3>Results</h3><div>There are multiple DHT for IBD with different characteristics and contents. We received 29 questionnaires. Almost 50% of the participants were 41-50 years old, the majority were women (83%) and 90% were gastroenterologists. A total of 96% reported the use of several DHT, but 20% used them occasionally or infrequently. Web pages were found the most used (62%). DHT are mostly used to get information (80%), followed by clinical practice issues (70%) and educational purposes (62%). G-Educainflamatoria website is the best known and most used HDS (96% and 64%, respectively). The main barriers to the use of DHT in IBD were the lack of time (55%), doubts about the benefit of DHT (50%) and the excess of information (40%).</div></div><div><h3>Conclusions</h3><div>Healthcare professionals involved in the care of patients with to IBD frequently use DHT, although actions are needed to optimize their use and to guarantee their efficient and safe use.</div></div>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":"47 9","pages":"Article 502200"},"PeriodicalIF":2.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Secondary uncovered versus fully-covered metal stents for the management of occluded stent in unresectable distal malignant biliary obstruction 在治疗无法切除的远端恶性胆道梗阻的闭塞支架时，二次覆盖与全覆盖金属支架的比较。

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-11-01 DOI: 10.1016/j.gastrohep.2024.502218

{"title":"Secondary uncovered versus fully-covered metal stents for the management of occluded stent in unresectable distal malignant biliary obstruction","authors":"","doi":"10.1016/j.gastrohep.2024.502218","DOIUrl":"10.1016/j.gastrohep.2024.502218","url":null,"abstract":"<div><h3>Introduction</h3><div>Self-expandable metallic stents (SEMS) have been widely placed for unresectable distal malignant biliary obstruction (UDMBO). However, the dysfunction rate is 19–40% and its treatment is controversial. We aimed asses the efficacy and safety of a secondary biliary stents (uncovered (UC) versus fully-covered (FC) stent) for the management of occluded SEMS.</div></div><div><h3>Patients and methods</h3><div>Between 2015 and June 2023, 41 patients with UDMBO underwent secondary biliary stent placement as “stent-in-stent” (20 FCSEMS and 21 UCSEMS). The primary outcomes were technical and clinical success of SEMS placement. Secondary outcomes included adverse events (AEs), patency and survival. Patients were prospectively followed until death or loss of follow-up.</div></div><div><h3>Results</h3><div>Technical (100% vs 85.5%) and clinical (100% vs 95.2%) success rates were similar in FCSEMS and UCSEMS groups. The median follow-up period was 510 days (range 290–630). The median duration of stent patency of FCSEMS (220 days, IQR 137.5–442.5) was longer than UCSEMS (150 days, IQR 110–362.5) (<em>P</em>          <!-->0.133, 0.026–0.690) were significant factors for overall survival. There were no remarkable differences in AEs.</div></div><div><h3>Conclusions</h3><div>The placement of additional biliary stent using the stent-in-stent method is an effective and safe rescue treatment for patients with UDMBO and occluded stent. In addition, the use of FCSEMS compared UCSEMS has unclear benefits regarding stent patency and overall survival.</div></div>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":"47 9","pages":"Article 502218"},"PeriodicalIF":2.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

PÉPTIDOS INMUNOGÉNICOS DEL GLUTEN EN EL ENTORNO PRENATAL: UN NUEVO DETERMINANTE EN EL EXPOSOMA CELÍACO

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-11-01 DOI: 10.1016/S0210-5705(24)00376-5

M.L. Moreno, M. González Rovira, C. Martínez Pancorbo, M. Martín-Cameán, A.M. Nájar-Moyano, M.M. Romero, E. de la Hoz, C. López-Beltrán, E. Mellado, J.l. Bartha Rasero, P. Brodin, A. Rodríguez Herrera, J.A. Sainz Bueno, C. Sousa

引用次数: 0

LA INFECCIÓN COMO DESENCADENANTE DE LA ENFERMEDAD CELÍACA ACTIVA

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-11-01 DOI: 10.1016/S0210-5705(24)00350-9

Á. Sanchiz, M.I. San Martín, S. García, F. Fernández-Bañares, H. Martínez-Blanco, L. Vaquero, M.Á. Ferrero, C. Núñez, L. Rodríguez-Aparicio, S. Vivas, M. Esteve, N. Navasa

引用次数: 0